|
|
Oliver G. McDonald, Brian R. Wamhoff, Mark H. Hoofnagle, Gary K. Owens
J Clin Invest. 2006;
116(1):36
doi:10.1172/JCI26505
Abstract |
Full text
| PDF
| Supplemental material

P
recise control of SMC transcription plays a major role in vascular development and pathophysiology. Serum response factor (SRF) controls SMC gene transcription via binding to CArG box DNA sequences found within genes that exhibit SMC-restricted expression. However, the mechanisms that regulate SRF association with CArG box DNA within native chromatin of these genes are unknown. Here we report that SMC-restricted binding of SRF to murine SMC gene CArG box chromatin is associated with patterns of posttranslational histone modifications within this chromatin that are specific to the SMC lineage in culture and in vivo, including methylation and acetylation to histone H3 and H4 residues. We found that the promyogenic SRF coactivator myocardin increased SRF association with methylated histones and CArG box chromatin during activation of SMC gene expression. In contrast, the myogenic repressor Kruppel-like factor 4 recruited histone H4 deacetylase activity to SMC genes and blocked SRF association with methylated histones and CArG box chromatin during repression of SMC gene expression. Finally, we observed deacetylation of histone H4 coupled with loss of SRF binding during suppression of SMC differentiation in response to vascular injury. Taken together, these findings provide novel evidence that SMC-selective epigenetic control of SRF binding to chromatin plays a key role in regulation of SMC gene expression in response to pathophysiological stimuli in vivo.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Dynamics of Srf, p300 and histone modifications during cardiac maturation in mouse
Markus Schueler, Qin Zhang, Jenny Schlesinger, Martje Tönjes, Silke R. Sperling
|
Mol. BioSyst.
|
2012 |
Epigenetic Control of Smooth Muscle Cell Differentiation and Phenotypic Switching in Vascular Development and Disease
Matthew R. Alexander, Gary K. Owens
|
Annu. Rev. Physiol.
|
2012 |
Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation
S. Allahverdian, P. S. Pannu, G. A. Francis
|
Cardiovascular Research
|
2012 |
Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling
J. M. Spin, L. Maegdefessel, P. S. Tsao
|
Cardiovascular Research
|
2012 |
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms.
Delphine Gomez, Aurélie Coyet, Véronique Ollivier, Xavier Jeunemaitre, Guillaume Jondeau, Jean-Baptiste Michel, Roger Vranckx
|
Cardiovascular Research
|
2011 |
Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells
Hao Yin, Yulan Jiang, Haijie Li, Jingjing Li, Yu Gui, Xi-Long Zheng
|
J. Cell. Physiol.
|
2011 |
Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy
Xing-Hua Liao, Nan Wang, Qing-Xi Liu, Tao Qin, Bo Cao, Dong-Sun Cao, Tong-Cun Zhang
|
IUBMB Life
|
2011 |
Nutrition in Epigenetics
Aurelian Bidulescu, Methode Bacanamwo
|
Nutrition in Epigenetics
|
2011 |
NO points to epigenetics in vascular development
B. Illi, C. Colussi, J. Rosati, F. Spallotta, S. Nanni, A. Farsetti, M. C. Capogrossi, C. Gaetano
|
Cardiovascular Research
|
2011 |
Vitamins & Hormones
Changqing Xie, Jifeng Zhang, Y. Eugene Chen
|
Stem Cell Regulators
|
2011 |
|